Cargando…
Reconsidering the Meaning of Curing Primary Breast Cancer as a Systemic Disease
Autores principales: | Kim, Ryungsa, Kin, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012902/ https://www.ncbi.nlm.nih.gov/pubmed/33816282 http://dx.doi.org/10.3389/fonc.2021.639420 |
Ejemplares similares
-
Current and Future Therapies for Immunogenic Cell Death and Related Molecules to Potentially Cure Primary Breast Cancer
por: Kim, Ryungsa, et al.
Publicado: (2021) -
Current Status and Prospects of Anesthesia and Breast Cancer: Does Anesthetic Technique Affect Recurrence and Survival Rates in Breast Cancer Surgery?
por: Kim, Ryungsa, et al.
Publicado: (2022) -
Clinical Perspectives in Addressing Unsolved Issues in (Neo)Adjuvant Therapy for Primary Breast Cancer
por: Kim, Ryungsa, et al.
Publicado: (2021) -
Breast cancer recurrence and survival rates in patients who underwent breast‐conserving surgery under non‐mechanically ventilated anesthesia
por: Kim, Ryungsa, et al.
Publicado: (2022) -
Outpatient breast-conserving surgery for breast cancer: Use of local and intravenous anesthesia and/or sedation may reduce recurrence and improve survival
por: Kim, Ryungsa, et al.
Publicado: (2020)